Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Price Negotiable
Price: To be negotiated
MOQ: To be negotiated
Delivery Time: To be negotiated
Brand: Combined detection reagent of troponin I, myoglobin and creatine kinase isoenzyme(cTnl/MYO/CK-MB)
Product Description

Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme Performance Index

 

CTnI/MYO/CK-MB Overview


The troponin I/ myoglobin/creatine kinase isoenzyme (cTnI/ Myo /CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great significance in the early diagnosis of acute myocardial diseases such as AMI

 

American Academy of Clinical Biochemistry (NACB) practice guidelines

All suspected patients with ACS should be tested for markers of myocardial necrosis

Troponin is the primary marker for the diagnosis of myocardial infarction

Myoglobin in combination with specific markers of myocardial necrosis, such as cTnI/CK-MB, may help to rule out or diagnose myocardial infarction more quickly

 

 

  MYO CK-MB cTnI
molecular weight 17.8KD 86KD 22.5KD
Rise time 1-2h 4-6h 3-6h
Peak time 6-9h 24h 12-16h
recovery time 18-30h 2-3d 4-10d
Clinical value

1. The most important index of AMI was excluded in the early stage

2. Recurrent diagnosis of AMI, and the best evaluation index of reperfusion treatment effect

1. Estimate infarct size or reinfarct

2. The most valuable non-ST segment elevation marker of MI

1. Preferred markers for the diagnosis of AMI

2. Judge the infarct size and risk stratification

 

 

cTnI/MYO/CK-MB Performance Index


Detection range sample size Sample type Test time
cTnI MYO CK-MB 60μl Whole blood / serum / plasma 15min
0.1~50ng/mL 10~200ng/mL 0.8~100ng/mL

 

 

 

CTnI/MYO/CK-MB Clinical Significance


  • It is helpful for early diagnosis and risk stratification of acute coronary syndrome
  • Determine the area of myocardial ischemia injury
  • Differential diagnosis of various causes of chest pain
  • Monitoring of myocardial injury caused by various causes
  • Evaluation of the clinical efficacy of certain therapeutic agents

 

Possibility of outcome  
cTnI CK-MB MYO Clinical possibility

+

+ + Myocardial infarction/myocardial injury can be diagnosed basically, and the occurrence time is 12-24 hours;
+ + - It can be basically diagnosed as myocardial infarction/myocardial injury, and the detection time is more than 1 day, which has passed the detection window period of Myo.
+ - - Myocardial infarction/myocardial injury has occurred for 2-3 days, and it is recommended to check again several hours later.
+ - + In patients with myocardial infarction/myocardial injury, the detection time may be longer than 3 days for symptoms, and patients suffer from reinjury or infarction size enlargement;
- + + Early myocardial infarction/myocardial injury/muscle injury, cTnI reexamination is recommended within 4-8 hours;

-

- + 1. Early myocardial infarction/myocardial injury, cTnI reexamination is recommended within 4-8 hours;
2. It may be caused by other injury diseases, such as creative work, skeletal muscle injury, liver and kidney disease;
- + - 1. For minor myocardial injury, it is recommended to reexamine cTnI within 4-8 hours;
2. It may be non-myocardial injury disease, and the detection time has passed the Myo window period;

-

- - Myocardial infarction/myocardial injury is basically ruled out. If highly suspected, it is recommended to check every 2 to 4 hours.

 

 

 

Application Department


Outpatient, emergency, physical examination center, cardiovascular, ICU, chest pain center and other departments

 

 

CTnI/MYO/CK-MB Clinical Comparison


 

 

Company profile


ZOS-F2100(Multi-Channel) 4ZOS-F2100(Multi-Channel) 5ZOS-F2100(Multi-Channel) 6ZOS-F2100(Multi-Channel) 7

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

 

 

 

 

Get in Touch

Have questions about our products or want to discuss a custom order? Our team is ready to help you.

Company Henan Lantian Medical Supplies Co.,Ltd.
Location Office Address: Building 4, No. 51 Jingbei 3rd Road, Jingkai Zone, Zhengzhou City. Henan Province,China.
Contact Person chen

Request A Quote

Please check your email address.
Your message must be at least 20 characters.